KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Net Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Net Margin for 17 consecutive years, with 103.87% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 21110.0% to 103.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 29.42% through Dec 2025, up 10127.0% year-over-year, with the annual reading at 29.42% for FY2025, 10127.0% up from the prior year.
  • Net Margin for Q4 2025 was 103.87% at Bio-Rad Laboratories, up from 52.36% in the prior quarter.
  • The five-year high for Net Margin was 525.84% in Q3 2021, with the low at 480.98% in Q1 2022.
  • Average Net Margin over 5 years is 10.75%, with a median of 13.87% recorded in 2023.
  • The sharpest move saw Net Margin crashed -61546bps in 2022, then surged 49117bps in 2023.
  • Over 5 years, Net Margin stood at 213.61% in 2021, then soared by 153bps to 113.35% in 2022, then crashed by -55bps to 51.34% in 2023, then crashed by -309bps to 107.24% in 2024, then soared by 197bps to 103.87% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 103.87%, 52.36%, and 48.77% for Q4 2025, Q3 2025, and Q2 2025 respectively.